Home
Commodore Capital reported a 9.9% stake in AN2 Therapeutics ANTX · 3,697,435 sh · passive holder
Trade details
- Type
- 5% stake report
- Report
- 13G passive
- Stake
- 9.9%
- Last report
- First report
- Shares held
- 3,697,435 sh
- Class
- Common Stock, par value $0.00001 per share
- Holder
- Commodore Capital
- Event date
- 26/03/09
- Filed
- 26/03/16
First 5%+ report · 9.9% stake
AN2 Therapeutics trades, last 26 weeks
What else happened in AN2 Therapeutics around then
Filed or reported within 30 days of the trade day · 02/07~04/08Commodore Capital's other 5% stake reports
- Commodore Capital
5% stakeJatt III Acquisition
5% stakeJatt III Acquisition
JTTT
5.2% stake
400,000 sh
5.2% stake
Filed 09/02
- Commodore Capital
5% stakeInflaRx
5% stakeInflaRx
IFRX
5.1% stake
7,475,000 sh
5.1% stake
Filed 08/17
- Commodore Capital
5% stakePalisade Bio
5% stakePalisade Bio
PALI
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeJatt II Acquisition
5% stakeJatt II Acquisition
JATT
0% stake
0 sh
0% stake
Filed 08/14
- Commodore Capital
5% stakeRelay Therapeutics
5% stakeRelay Therapeutics
RLAY
5.5% stake
12,000,000 sh
5.5% stake
Filed 08/14
